Basel, Switzerland (ots/PRNewswire) - - Roche Also Provides Comment on Results of "IDEAL" Trial Roche today announced that compelling new data from three studies indicate that chronic hepatitis C patients who received PEGASYS(R) (peginterferon alfa-2a) plus COPEGUS(R) (ribavirin) had a greater chance of ...
Basel, Switzerland (ots/PRNewswire) - - R1626 Also Shows a High Barrier to the Development of Resistance Roche's investigational treatment for hepatitis C, R1626, has shown an impressive end-of-treatment response rate when given in combination with PEGASYS(R) (peginterferon alfa-2a) and ...
Basel, Switzerland (ots/PRNewswire) - - No Nucleoside/Nucleotide Analogue Treatments Have Shown Similar Results New data revealed today show that a significant number of patients with chronic hepatitis B virus infection who received PEGASYS(R) (peginterferon alfa-2a) treatment achieved clearance of ...
Ingelheim, Germany (ots/PRNewswire) - - For non-US Healthcare Media - Abstract # 163O. von Pawel. Proffered Papers 6 - Advanced NSCLC - Latest Phase II Data for Boehringer Ingelheim's New Cancer Drug in Development Presented Monotherapy treatment with the triple angiokinase inhibitor(1) BIBF 1120 ...
Paris (ots/PRNewswire) - - Third consecutive Quarter of Improved Margins - Continued Refocusing of the Product Portfolio Following the meeting of its Board of Directors, Valeo presented its first quarter 2008 results. (in EUR million) 1 January - 31 March 2008* 2007** change Total operating revenues 2,473 2,499 ...
COLLEGEVILLE, Pennsylvania and TARRYTOWN, New York, April 24 (ots/PRNewswire) -- - Final Decision from European Commission Expected by Mid-2008 Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received a ...
Liverpool, England (ots/PRNewswire) - - Irrespective of Budgetary Restrictions, etanercept Dose Escalation Remains Low Suggesting etanercept Achieves Sustained Efficacy and is a Cost Effective Treatment for Rheumatoid Arthritis New pan-European data presented today at the British Society of Rheumatology's ...
Collegeville, Pennsylvania (ots/PRNewswire) - - Wyeth Withdraws European Application Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that it is withdrawing its application for an extension to the European Marketing Authorization for TYGACIL(R) (tigecycline). This extension sought approval of TYGACIL for the treatment ...
Calgary, Canada (ots/PRNewswire) - - Phase 1a Study Objectives Were Met - TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has completed dosing of its Phase 1a safety, tolerability and pharmacokinetics study for its lead drug candidate, RVX-208, which addresses the dyslipidemia market. "Initial results from the emerging data are very good," ...
Heilbronn, Germany (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of the new LF coil driver IC ATA5279 designed for Passive Entry Go (PEG) and Passive Go (PG) hands-free car access systems. This is industry's first and only off-the-shelf antenna driver IC. Compared to ...
Rousset, France (ots/PRNewswire) - - One of Leading Products Selected by Editors and Industry Experts Atmel(R) Corporation (Nasdaq: ATML) announced today that its CAP(TM) customizable microcontroller has been named as one of the Products of the Year by Electronic Products China (EPC) Magazine. The selection was made by a panel of editors and industry experts ...
Paris (ots/PRNewswire) - Valeo Lighting Systems' Martos plant in Spain has won the Prince Felipe Award for Business Competitiveness, the highest distinction given to a company in Spain. "It is an honor for Valeo to receive this prestigious award highlighting the importance of quality, innovation and operational excellence, which are at the heart of our Group's ...
BERLIN - European Breast Cancer Conference (EBCC), April 18 (ots/PRNewswire) -- - For Non-UK and Non-US Media Only - Herceptin Offers Women With HER2-Positive Breast Cancer the Best Chance of a Cure New data presented today as part of a late breaking plenary session at EBCC in Berlin showed that Herceptin (trastuzumab) in combination with standard ...
St. Peter Port, Guernsey (ots/PRNewswire) - ECAS S.a.r.l, an indirect wholly-owned subsidiary of European Capital Limited (LSE: ECAS) ("European Capital"), announced today investments totaling euro 97 million in three companies made in the first quarter of 2008. The investments were led by the London office of European Capital Financial Services Limited ...
Abbotsford, Canada (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) is pleased to announce that 70% of the confirmation drilling of the historical Mokambo sulphide copper deposit has been completed towards its objective of preparing a NI 43-101 Resource Report. Sulphide Confirmation Drill Program The Company is in the process of drilling five ...
St. Peter Port, Guernsey (ots/PRNewswire) - - Shareholder Call Scheduled for 14 May European Capital Limited (LSE: ECAS) announced today it will report first quarter 2008 earnings on Tuesday 13 May 2008. European Capital invites shareholders, analysts and other interested persons to attend the European Capital Shareholder Call on Wednesday 14 May at 14:30 BST (9:30 EDT). Callers within the UK can ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media Outside the U.S.A. - Studies Demonstrate Positive and Rapid Impact of Pramipexole on the Core Symptoms of Restless Legs Syndrome and Sleep Disturbance A new study has shown that pramipexole (Mirapexin(R)/Sifrol(R)) can significantly reduce ...
Abbotsford, Canada (ots/PRNewswire) - ICS Copper Systems Ltd (The company or ICS), (ICX:TSX.V) is pleased to announce that Mr. Richard Molyneux, BSc(Hons) Geo, PrNatSc(RSA), joined the Board of Directors of ICS Copper Systems Ltd effective April 11 2008. Mr. Molyneux's valuable experience in various types of heavy mineral and geochemical sampling, photo-geological ...
Exton, Pennsylvania (ots/PRNewswire) - - Upon Marketing Authorization Orphan Status Would Provide for Ten Years of Market Exclusivity in the European Union for Both Investigational Treatments Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that the European Commission has granted orphan drug status to the monoclonal ...
San Jose, California (ots/PRNewswire) - - AT91CAP7X-DK Includes ARM7-based Microcontroller with 80K LC FPGA Atmel(R) Corporation (Nasdaq: ATML) today announced its AT91CAP7X-DK development kit for designers to develop, emulate, and ultimately migrate ARM7(TM)-plus-FPGA designs to Atmel's CAP7 customizable microcontrollers. Atmel's CAP7 customizable MCU is an ARM7-based microcontroller with a ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media, Outside the US Only Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus(R) 80/25 in all 27 EU member ...
Botaneco and SemBioSys Genetics Inc.
Calgary, Canada (ots/PRNewswire) - - Natural Hydresia(TM) G2 Offers Enhanced Formulation Flexibility With a Globally Accepted Preservative System Botaneco, a wholly owned subsidiary of SemBioSys Genetics Inc. (TSX: SBS), focused on the development and commercialization of oleosome technology in personal care, OTC and topical pharmaceutical markets, today announced the launch of its second generation oleosome ...
Rousset, France and Pittsburgh (ots/PRNewswire) - - LinuxLink Subscription Accelerates Embedded Development Atmel(R) Corporation (Nasdaq: ATML) and TimeSys(R) announced today embedded Linux(R) support for Atmel's ARM9(TM)-based AT91CAP9 customizable microcontroller. Ideal for rapid design validation, TimeSys is offering a free Board Support Package (BSP) for ...
San Diego, California (ots/PRNewswire) - - Newly Established Organization Presents Data on Advancing Compounds at AACR - Ortho Biotech Oncology Research & Development (ORD), a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., will announce results from studies of three innovative ...
Stichting Shell Reserves Compensation Foundation and Royal Dutch Shell plc
The Hague (ots/PRNewswire) - In the news release, "Amsterdam Court of Appeals Sets Date for Hearing With Respect to Shell Securities Class Settlement of Reserve-Related Claims With European and Other Non US Investors" issued on 11 Apr 2008 05:30 GMT, by Stichting Shell Reserves Compensation Foundation and Royal ...
Tokyo, Japan (ots/PRNewswire) - E2007 (perampanel) is a first-in-class, orally administered, highly selective non-competitive AMPA-type glutamate receptor antagonist, in development by Eisai (TSE:4523) for several indications, including Parkinson's disease, neuropathic pain, epilepsy, multiple sclerosis and ...
The Hague (ots/PRNewswire) - Shell (i), Stichting Shell Reserves Compensation Foundation (the Foundation), VEB (the Dutch Shareholders Association), APG, All Pensions Group (on behalf of pension fund ABP) and PGGM (on behalf of Stichting Pensioenfonds Zorg en Welzijn) have announced that the Amsterdam Court of ...
Vancouver, Canada (ots/PRNewswire) - Oremex Resources Inc. (TSX-V: ORM) (the Company) today provided an update on the status of surface access at their flagship Tejamen Silver Property (Tejamen), State of Durango, Mexico. Discussions continue to progress with the Ejido of Tejamen (governing authority for the village and surrounding communal lands) with the guidance and public support of the Secretary of State for the Governor of Durango and the President of Nuevo Ideal, ...
Istanbul, Turkey (ots/PRNewswire) - - Multi-national study will follow 60,000 women for 5 years Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the globe. Launch of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) was announced today at ...
Tunis, Tunisia (ots/PRNewswire) - - 6th Merial Symposium on Parasitosis & Arthropod-Borne Diseases: A Bio- Mathematical Model for the Risk Evaluation of Flea & Tick Population The 6th Merial Symposium on Parasitosis and Arthropod-Borne Diseases opens today in Tunis gathering over 120 climatology, parasitology and veterinary specialists to discuss the impact of global warming on parasitosis(1) and vector-borne ...